Synaptogenix, Inc.
1185 Avenue of the Americas, 3rd Floor
New York, New York 10036
July 2, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jane Park
| Re: | Synaptogenix, Inc. |
Registration Statement on Form S-1
File No. 333-257364
Request for Acceleration
Dear Ms. Park:
Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Synaptogenix, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-257364), so that it may become effective at 5:00 p.m. (Washington, D.C. time) on July 6, 2021, or as soon thereafter as practicable.
Please call Daniel Bagliebter, of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any comments or questions regarding this matter.
| Very truly yours, | ||
| Synaptogenix, Inc. | ||
| By: | /s/ Robert Weinstein | |
| Name: Robert Weinstein | ||
| Title: Chief Financial Officer | ||
| cc: | Synaptogenix, Inc. |
| Alan Tuchman, M.D. | |
| Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. | |
| Daniel A. Bagliebter, Esq. |
